Rock Springs Capital Master Fund LP's Net Worth
$0
Who is Rock Springs Capital Master Fund LP?
Rock Springs Capital Master Fund LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Atea Pharmaceuticals, Inc., Theseus Pharmaceuticals, Inc., Verve Therapeutics, Inc., Xilio Therapeutics, Inc., Inozyme Pharma, Inc., Tempest Therapeutics, Inc., Homology Medicines, Inc., and IMARA Inc..
SEC CIK
Rock Springs Capital Master Fund LP's CIK is 0001735393
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Atea Pharmaceuticals, Inc. (AVIR) Snapshot price: $3.47
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +114.75% | 1.94M |
$24.00 | $6,000,000.00 | 3.64M |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +196.57% | 686.65K |
$16.00 | $4,000,000.00 | 1.04M |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.08M |
$19.00 |
—
| 1.08M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +186.10% | 1.41M |
$16.00 | $8,000,000.00 | 2.16M |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.07M |
$16.00 |
—
| 1.07M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||